Testing Adaptive Therapy Protocols Using Gemcitabine and Capecitabine in a Preclinical Model of Endocrine-Resistant Breast Cancer is a research paper published in Cancers (2024). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: U54 CA217376
NIH
Grant: U2C CA233254
NIH
Grant: R01 CA140657
NIH
Grant: U01CA232382
NIH
Grant: BC132057
NIH
Grant: ADHS18-198847
National Institutes of Health
Grant: 3U2CCA233254-01S1
Extension to the HTAN Pre-Cancer Atlas Project
National Institutes of Health
Grant: 5U54CA217376-05
Arizona Cancer and Evolution Center (ACE)
National Institutes of Health
Grant: 5U01CA232382-03
Eco-Evolutionary dynamics of NSCLC to immunotherapy: Response and Resistance
National Institutes of Health
Grant: 5R01CA140657-12
Modeling Neoplastic Progression in Barrett's Esophagus - Renewal -2
Fields of Study
Keywords
Sustainable Development Goals